share_log

特一药业(002728.SZ)：2023年度净利润增42.07%至2.53亿元 拟10转4派5元

Teyi Pharmaceutical (002728.SZ): Net profit increased by 42.07% to 253 million yuan in 2023, plans to convert 10 to 4 to 5 yuan

Gelonghui Finance ·  Mar 7 05:31

Gelonghui, March 7 | Teyi Pharmaceutical (002728.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 1,067 million yuan, an increase of 20.38%; achieved net profit attributable to shareholders of listed companies of 253 million yuan, an increase of 42.07% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 249 million yuan, an increase of 43.61% year on year; basic income per share is 0.77 yuan; it plans to distribute cash dividends of 5.00 yuan (tax included) to all shareholders for every 10 shares, using capital reserves to the whole Shareholders added 4 shares for every 10 shares.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment